price
EN
NASDAQ · ENTX
Entera Bio Ltd.
Healthcare · Biotechnology
$3.08
Down-$0.11 (-3.45%)
Updated Aug 28, 2026, 4:59 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 101.79M
- P/E ratio
- -41.77
- Dividend yield
- 0.00%
- 52-week range
- $0.91 – $4.20
- Volume
- 240.68K
- Avg. volume
- 154.41K
Price performance
ENTX price history
1M range · 21 trading sessions · Daily adjusted prices
ENTX closed at $3.08 after 21 trading sessions, up 4.41% for the selected period.
- Last close
- $3.08
- Period change
- +4.41%
- Period low
- $2.80
- Period high
- $3.47
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $3.20 | $3.41 | $3.03 | $3.08 | 240.68K |
| Aug 26, 2026 | $3.46 | $3.47 | $3.10 | $3.19 | 523.31K |
| Aug 25, 2026 | $3.42 | $3.5595 | $3.4052 | $3.47 | 429.97K |
| Aug 24, 2026 | $3.28 | $3.47 | $3.20 | $3.42 | 258.13K |
| Aug 21, 2026 | $3.22 | $3.34 | $3.14 | $3.23 | 441.3K |
| Aug 20, 2026 | $3.01 | $3.33 | $3.00 | $3.22 | 468.47K |
| Aug 19, 2026 | $2.93 | $3.2099 | $2.8797 | $3.11 | 696.06K |
| Aug 18, 2026 | $2.89 | $2.969 | $2.81 | $2.89 | 261.72K |
| Aug 17, 2026 | $2.83 | $2.97 | $2.82 | $2.90 | 305.88K |
| Aug 14, 2026 | $2.85 | $2.92 | $2.75 | $2.89 | 278.33K |
| Aug 13, 2026 | $2.78 | $2.92 | $2.76 | $2.87 | 246.48K |
| Aug 12, 2026 | $3.03 | $3.03 | $2.75 | $2.80 | 410.05K |
| Aug 11, 2026 | $2.98 | $3.0592 | $2.754 | $3.00 | 487.99K |
| Aug 10, 2026 | $2.83 | $3.10 | $2.66 | $3.04 | 727.31K |
| Aug 7, 2026 | $2.80 | $2.97 | $2.80 | $2.87 | 244.95K |
| Aug 6, 2026 | $2.79 | $2.99 | $2.725 | $2.82 | 387.93K |
| Aug 5, 2026 | $2.84 | $2.84 | $2.70 | $2.81 | 308.52K |
| Aug 4, 2026 | $2.93 | $2.99 | $2.74 | $2.87 | 841.55K |
| Aug 3, 2026 | $2.91 | $3.05 | $2.76 | $2.96 | 1.1M |
| Jul 31, 2026 | $2.95 | $3.20 | $2.92 | $2.99 | 1.06M |
| Jul 30, 2026 | $3.06 | $3.06 | $2.6607 | $2.95 | 1.39M |
Latest ENTX news
The latest Smart Investors Daily articles mentioning ENTX.
Stock researchResearch & News · Competitors
Loading stock research…

